We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CERS market cap is 332.43M. The company's latest EPS is USD -0.2019 and P/E is -8.87.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 47.25M | 53.34M | 43.4M | 55.55M | 50.66M |
| Operating Income | -5.24M | 976k | -7.98M | 1.19M | -961k |
| Net Income | -7.27M | -1.33M | -9.69M | -5.78M | -2.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 93.77M | 114.25M | 159.52M | 162.05M | 186.8M |
| Operating Income | -66.23M | -58.33M | -48.94M | -62.08M | -30.05M |
| Net Income | -71.24M | -59.86M | -54.37M | -42.78M | -37.49M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 205.84M | 197.75M | 189.14M | 185.5M | 189.54M |
| Total Liabilities | 156.82M | 144.3M | 138.97M | 135.2M | 135.26M |
| Total Equity | 49.02M | 53.44M | 50.16M | 50.3M | 54.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 165.54M | 221.42M | 237.5M | 218.09M | 197.75M |
| Total Liabilities | 108.48M | 117.61M | 151.88M | 149.53M | 144.3M |
| Total Equity | 57.05M | 103.81M | 85.62M | 68.56M | 53.44M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.99M | -43.17M | 1.96M | 2.36M | 6.43M |
| Investing | 408k | 8.62M | 1.45M | -5.66M | -844k |
| Financing | 9.49M | 10.67M | 5.56M | 4.16M | 4.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -65.84M | -40.74M | -33.92M | -25.62M | -43.17M |
| Investing | 28.19M | -49.56M | 12.69M | 8.46M | 8.62M |
| Financing | 43.49M | 91.78M | 34.29M | 4.19M | 10.67M |
| Market Cap | 332.43M |
| Price to Earnings Ratio | -8.87 |
| Price to Sales Ratio | 1.78 |
| Price to Cash Ratio | 28.55 |
| Price to Book Ratio | 6.22 |
| Dividend Yield | - |
| Shares Outstanding | 185.72M |
| Average Volume (1 week) | 1.82M |
| Average Volume (1 Month) | 1.46M |
| 52 Week Change | 6.55% |
| 52 Week High | 2.585 |
| 52 Week Low | 1.375 |
| Spread (Intraday) | 0.1 (5.56%) |
| Company Name | Cerus Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cerus.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
